|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-4-19
|
|
pubmed:abstractText |
Acute promyelocytic leukemia (APL) frequently causes disseminated intravascular coagulation that can worsen with cytotoxic chemotherapy but improve with the therapeutic differentiating agents, all trans retinoic acid (ATRA) and arsenic trioxide (As(2)O(3)). APL cells display tissue factor but the relationship of tissue factor and other procoagulant activity to phosphatidylserine (PS) exposure is largely unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Arsenicals,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Factor Xa,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Milk Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oxides,
http://linkedlifedata.com/resource/pubmed/chemical/PAS-6-7 glycoprotein, Bos taurus,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylserines,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboplastin,
http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin,
http://linkedlifedata.com/resource/pubmed/chemical/arsenic trioxide
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1538-7836
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
773-82
|
|
pubmed:meshHeading |
pubmed-meshheading:20102487-Adolescent,
pubmed-meshheading:20102487-Adult,
pubmed-meshheading:20102487-Antineoplastic Agents,
pubmed-meshheading:20102487-Arsenicals,
pubmed-meshheading:20102487-Blood Coagulation,
pubmed-meshheading:20102487-Blood Coagulation Tests,
pubmed-meshheading:20102487-Cell Differentiation,
pubmed-meshheading:20102487-Cell Line, Tumor,
pubmed-meshheading:20102487-Cell Membrane,
pubmed-meshheading:20102487-Cell Survival,
pubmed-meshheading:20102487-Daunorubicin,
pubmed-meshheading:20102487-Etoposide,
pubmed-meshheading:20102487-Factor Xa,
pubmed-meshheading:20102487-Female,
pubmed-meshheading:20102487-Flow Cytometry,
pubmed-meshheading:20102487-Humans,
pubmed-meshheading:20102487-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:20102487-Male,
pubmed-meshheading:20102487-Membrane Glycoproteins,
pubmed-meshheading:20102487-Microscopy, Confocal,
pubmed-meshheading:20102487-Milk Proteins,
pubmed-meshheading:20102487-Oxides,
pubmed-meshheading:20102487-Phosphatidylserines,
pubmed-meshheading:20102487-Thrombin,
pubmed-meshheading:20102487-Thromboplastin,
pubmed-meshheading:20102487-Tretinoin,
pubmed-meshheading:20102487-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia.
|
|
pubmed:affiliation |
Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China. jinzhouh85@163.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
